Explore optical genome mapping (OGM), a groundbreaking tool modernizing genomic integrity and off-target analysis in various samples, vital in cell and gene therapy development. Dr. Alex Hastie, VP of Clinical and Scientific Affairs at Bionano, will provide an overview of the rapidly advancing application of OGM for cell and gene therapy research. Learn about its role in characterizing samples like induced pluripotent stem cells (iPSCs) and how the OGM workflow can potentially elevate quality, safety, and risk assessment standards in therapy development by verifying genomic integrity at high resolution.